Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study

BACKGROUND: A competitive market for off-patent biologicals leads to more affordable and high-quality healthcare. In recent years, Belgium has been characterized by its low use of biosimilars and by its shifts from off-patent biologicals toward new alternative therapies. Yet, the prescribing decisio...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandenplas, Yannick, Simoens, Steven, Van Wilder, Philippe, Vulto, Arnold G., Turk, Florian, Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520107/
https://www.ncbi.nlm.nih.gov/pubmed/36175885
http://dx.doi.org/10.1186/s12913-022-08591-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520107/
https://www.ncbi.nlm.nih.gov/pubmed/36175885
http://dx.doi.org/10.1186/s12913-022-08591-1

Ejemplares similares